Atlas Brown Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,049 shares of the healthcare conglomerate’s stock after buying an additional 66 shares during the period. Atlas Brown Inc.’s holdings in UnitedHealth Group were worth $801,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Amundi acquired a new position in shares of UnitedHealth Group during the second quarter worth $680,292,000. Jennison Associates LLC lifted its position in shares of UnitedHealth Group by 205.8% during the second quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock worth $779,944,000 after purchasing an additional 1,310,783 shares in the last quarter. Macquarie Group Ltd. lifted its position in shares of UnitedHealth Group by 311.9% during the second quarter. Macquarie Group Ltd. now owns 1,622,199 shares of the healthcare conglomerate’s stock worth $649,595,000 after purchasing an additional 1,228,389 shares in the last quarter. State Street Corp lifted its position in shares of UnitedHealth Group by 1.9% during the second quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock worth $17,831,807,000 after purchasing an additional 838,941 shares in the last quarter. Finally, Morgan Stanley lifted its position in shares of UnitedHealth Group by 9.7% during the second quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock worth $3,481,120,000 after purchasing an additional 768,188 shares in the last quarter. 86.20% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages recently issued reports on UNH. Wells Fargo & Company lifted their price target on shares of UnitedHealth Group from $478.00 to $520.00 and gave the stock an “overweight” rating in a research note on Monday, October 25th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research note on Tuesday, November 16th. SVB Leerink began coverage on shares of UnitedHealth Group in a research note on Monday, September 27th. They issued an “outperform” rating and a $480.00 price target for the company. Royal Bank of Canada lifted their price target on shares of UnitedHealth Group from $473.00 to $476.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Finally, Credit Suisse Group boosted their target price on shares of UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. One analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $477.35.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, topping the consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.51 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be issued a $1.45 dividend. This represents a $5.80 annualized dividend and a yield of 1.29%. The ex-dividend date is Friday, December 3rd. UnitedHealth Group’s payout ratio is currently 35.98%.
In other news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Friday, September 17th. The stock was sold at an average price of $419.00, for a total value of $1,047,500.00. The disclosure for this sale can be found here. Insiders sold a total of 82,500 shares of company stock valued at $36,855,125 over the last three months. 0.55% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Read More: Capital Gains Distribution
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.